Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues.

Indolizines are heteroaromatic compounds, and their synthetic analogues have reportedly showed promising pharmacological properties. In this study, a series of synthetic 7-methoxy-indolizine derivatives were synthesised, characterised and evaluated for in vitro whole-cell anti-tuberculosis (TB) scre...

Full description

Bibliographic Details
Main Authors: Katharigatta Narayanaswamy Venugopala, Sandeep Chandrashekharappa, Melendhran Pillay, Hassan H Abdallah, Fawzi M Mahomoodally, Subhrajyoti Bhandary, Deepak Chopra, Mahesh Attimarad, Bandar E Aldhubiab, Anroop B Nair, Nagaraja Sreeharsha, Mohamed A Morsy, Shinu Pottathil, Rashmi Venugopala, Bharti Odhav, Koleka Mlisana
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0217270
id doaj-3b6fc19ce5624792ae7792d084c27f38
record_format Article
spelling doaj-3b6fc19ce5624792ae7792d084c27f382021-03-03T20:38:50ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-01146e021727010.1371/journal.pone.0217270Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues.Katharigatta Narayanaswamy VenugopalaSandeep ChandrashekharappaMelendhran PillayHassan H AbdallahFawzi M MahomoodallySubhrajyoti BhandaryDeepak ChopraMahesh AttimaradBandar E AldhubiabAnroop B NairNagaraja SreeharshaMohamed A MorsyShinu PottathilRashmi VenugopalaBharti OdhavKoleka MlisanaIndolizines are heteroaromatic compounds, and their synthetic analogues have reportedly showed promising pharmacological properties. In this study, a series of synthetic 7-methoxy-indolizine derivatives were synthesised, characterised and evaluated for in vitro whole-cell anti-tuberculosis (TB) screening against susceptible (H37Rv) and multi-drug-resistant (MDR) strains of Mycobacterium tuberculosis (MTB) using the resazurin microplate assay method. The cytotoxicity was evaluated using the MTT assay. In silico molecular-docking study was conducted for compounds 5a-j against enoyl-[acyl-carrier] protein reductase, a key enzyme of the type II fatty acid synthesis that has attracted much interest for the development of novel anti-TB compounds. Thereafter, molecular dynamic (MD) simulation was undertaken for the most active inhibitors. Compounds 5i and 5j with the methoxy functional group at the meta position of the benzoyl group, which was at the third position of the indolizine nucleus, demonstrated encouraging anti-TB activity against MDR strains of MTB at 16 μg/mL. In silico studies showed binding affinity within the range of 7.07-8.57 kcal/mol, with 5i showing the highest binding affinity. Hydrogen bonding, π-π- interactions, and electrostatic interactions were common with the active site. Most of these interactions occurred with the catalytic amino acids (Pro193, Tyr158, Phe149, and Lys165). MD simulation showed that 5j possessed the highest binding affinity toward the enzyme, according to the two calculation methods (MM/PBSA and MM/GBSA). The single-crystal X-ray studies of compounds 5c and 5d revealed that the molecular arrangements in these two structures were mostly guided by C-H···O hydrogen-bonded dimeric motifs and C-H···N hydrogen bonds, while various secondary interactions (such as π···π and C-H···F) also contributed to crystal formation. Compounds 5a, 5c, 5i, and 5j exhibited no toxicity up to 500 μg/mL. In conclusion, 5i and 5j are promising anti-TB compounds that have shown high affinity based on docking and MD simulation results.https://doi.org/10.1371/journal.pone.0217270
collection DOAJ
language English
format Article
sources DOAJ
author Katharigatta Narayanaswamy Venugopala
Sandeep Chandrashekharappa
Melendhran Pillay
Hassan H Abdallah
Fawzi M Mahomoodally
Subhrajyoti Bhandary
Deepak Chopra
Mahesh Attimarad
Bandar E Aldhubiab
Anroop B Nair
Nagaraja Sreeharsha
Mohamed A Morsy
Shinu Pottathil
Rashmi Venugopala
Bharti Odhav
Koleka Mlisana
spellingShingle Katharigatta Narayanaswamy Venugopala
Sandeep Chandrashekharappa
Melendhran Pillay
Hassan H Abdallah
Fawzi M Mahomoodally
Subhrajyoti Bhandary
Deepak Chopra
Mahesh Attimarad
Bandar E Aldhubiab
Anroop B Nair
Nagaraja Sreeharsha
Mohamed A Morsy
Shinu Pottathil
Rashmi Venugopala
Bharti Odhav
Koleka Mlisana
Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues.
PLoS ONE
author_facet Katharigatta Narayanaswamy Venugopala
Sandeep Chandrashekharappa
Melendhran Pillay
Hassan H Abdallah
Fawzi M Mahomoodally
Subhrajyoti Bhandary
Deepak Chopra
Mahesh Attimarad
Bandar E Aldhubiab
Anroop B Nair
Nagaraja Sreeharsha
Mohamed A Morsy
Shinu Pottathil
Rashmi Venugopala
Bharti Odhav
Koleka Mlisana
author_sort Katharigatta Narayanaswamy Venugopala
title Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues.
title_short Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues.
title_full Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues.
title_fullStr Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues.
title_full_unstemmed Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues.
title_sort computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2019-01-01
description Indolizines are heteroaromatic compounds, and their synthetic analogues have reportedly showed promising pharmacological properties. In this study, a series of synthetic 7-methoxy-indolizine derivatives were synthesised, characterised and evaluated for in vitro whole-cell anti-tuberculosis (TB) screening against susceptible (H37Rv) and multi-drug-resistant (MDR) strains of Mycobacterium tuberculosis (MTB) using the resazurin microplate assay method. The cytotoxicity was evaluated using the MTT assay. In silico molecular-docking study was conducted for compounds 5a-j against enoyl-[acyl-carrier] protein reductase, a key enzyme of the type II fatty acid synthesis that has attracted much interest for the development of novel anti-TB compounds. Thereafter, molecular dynamic (MD) simulation was undertaken for the most active inhibitors. Compounds 5i and 5j with the methoxy functional group at the meta position of the benzoyl group, which was at the third position of the indolizine nucleus, demonstrated encouraging anti-TB activity against MDR strains of MTB at 16 μg/mL. In silico studies showed binding affinity within the range of 7.07-8.57 kcal/mol, with 5i showing the highest binding affinity. Hydrogen bonding, π-π- interactions, and electrostatic interactions were common with the active site. Most of these interactions occurred with the catalytic amino acids (Pro193, Tyr158, Phe149, and Lys165). MD simulation showed that 5j possessed the highest binding affinity toward the enzyme, according to the two calculation methods (MM/PBSA and MM/GBSA). The single-crystal X-ray studies of compounds 5c and 5d revealed that the molecular arrangements in these two structures were mostly guided by C-H···O hydrogen-bonded dimeric motifs and C-H···N hydrogen bonds, while various secondary interactions (such as π···π and C-H···F) also contributed to crystal formation. Compounds 5a, 5c, 5i, and 5j exhibited no toxicity up to 500 μg/mL. In conclusion, 5i and 5j are promising anti-TB compounds that have shown high affinity based on docking and MD simulation results.
url https://doi.org/10.1371/journal.pone.0217270
work_keys_str_mv AT katharigattanarayanaswamyvenugopala computationalcrystallographicstudiescytotoxicityandantitubercularactivityofsubstituted7methoxyindolizineanalogues
AT sandeepchandrashekharappa computationalcrystallographicstudiescytotoxicityandantitubercularactivityofsubstituted7methoxyindolizineanalogues
AT melendhranpillay computationalcrystallographicstudiescytotoxicityandantitubercularactivityofsubstituted7methoxyindolizineanalogues
AT hassanhabdallah computationalcrystallographicstudiescytotoxicityandantitubercularactivityofsubstituted7methoxyindolizineanalogues
AT fawzimmahomoodally computationalcrystallographicstudiescytotoxicityandantitubercularactivityofsubstituted7methoxyindolizineanalogues
AT subhrajyotibhandary computationalcrystallographicstudiescytotoxicityandantitubercularactivityofsubstituted7methoxyindolizineanalogues
AT deepakchopra computationalcrystallographicstudiescytotoxicityandantitubercularactivityofsubstituted7methoxyindolizineanalogues
AT maheshattimarad computationalcrystallographicstudiescytotoxicityandantitubercularactivityofsubstituted7methoxyindolizineanalogues
AT bandarealdhubiab computationalcrystallographicstudiescytotoxicityandantitubercularactivityofsubstituted7methoxyindolizineanalogues
AT anroopbnair computationalcrystallographicstudiescytotoxicityandantitubercularactivityofsubstituted7methoxyindolizineanalogues
AT nagarajasreeharsha computationalcrystallographicstudiescytotoxicityandantitubercularactivityofsubstituted7methoxyindolizineanalogues
AT mohamedamorsy computationalcrystallographicstudiescytotoxicityandantitubercularactivityofsubstituted7methoxyindolizineanalogues
AT shinupottathil computationalcrystallographicstudiescytotoxicityandantitubercularactivityofsubstituted7methoxyindolizineanalogues
AT rashmivenugopala computationalcrystallographicstudiescytotoxicityandantitubercularactivityofsubstituted7methoxyindolizineanalogues
AT bhartiodhav computationalcrystallographicstudiescytotoxicityandantitubercularactivityofsubstituted7methoxyindolizineanalogues
AT kolekamlisana computationalcrystallographicstudiescytotoxicityandantitubercularactivityofsubstituted7methoxyindolizineanalogues
_version_ 1714821375611371520